BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25122726)

  • 1. The global anti-phospholipid syndrome score in primary APS.
    Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Rheumatology (Oxford); 2015 Jan; 54(1):134-8. PubMed ID: 25122726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GAPSS: the Global Anti-Phospholipid Syndrome Score.
    Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Rheumatology (Oxford); 2013 Aug; 52(8):1397-403. PubMed ID: 23315788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.
    Zuily S; de Laat B; Mohamed S; Kelchtermans H; Shums Z; Albesa R; Norman GL; Lamboux-Matthieu C; Rat AC; Ninet J; Magy-Bertrand N; Pasquali JL; Lambert M; Lorcerie B; Kaminsky P; Guillemin F; Regnault V; Wahl D;
    Rheumatology (Oxford); 2015 Nov; 54(11):2071-5. PubMed ID: 26163690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.
    Sciascia S; Radin M; Sanna G; Cecchi I; Roccatello D; Bertolaccini ML
    Rheumatology (Oxford); 2018 Apr; 57(4):661-665. PubMed ID: 29342292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
    Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
    Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic risk assessment in APS: the Global APS Score (GAPSS).
    Sciascia S; Bertolaccini ML
    Lupus; 2014 Oct; 23(12):1286-7. PubMed ID: 25228728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.
    Radin M; Schreiber K; Costanzo P; Cecchi I; Roccatello D; Baldovino S; Bazzan M; Cuadrado MJ; Sciascia S
    Int J Cardiol; 2017 Aug; 240():72-77. PubMed ID: 28385357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome.
    Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Zhou Z; Jia J; Wang Z; Zhou J; Norman GL; Wang X; Yang C; Shi H
    Thromb Res; 2020 Jan; 185():142-149. PubMed ID: 31816554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
    Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
    Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent validation of the adjusted GAPSS: Role of thrombotic risk assessment in the real-life setting.
    Fernandez Mosteirin N; Saez Comet L; Salvador Osuna C; Calvo Villas JM; Velilla Marco J
    Lupus; 2017 Oct; 26(12):1328-1332. PubMed ID: 28387637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management.
    Radin M; Ugolini-Lopes MR; Sciascia S; Andrade D
    Semin Arthritis Rheum; 2018 Aug; 48(1):117-120. PubMed ID: 29395258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
    Nascimento IS; Radin M; Gândara APR; Sciascia S; de Andrade DCO
    Lupus; 2020 Jun; 29(7):676-685. PubMed ID: 32279584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The scoring system for the risk-stratification in patients with the antiphospholipid syndrome].
    Oku K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):435-441. PubMed ID: 29367527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
    Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.
    Oku K; Amengual O; Yasuda S; Atsumi T
    Curr Rheumatol Rep; 2017 Aug; 19(8):51. PubMed ID: 28741233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influencing factors of thrombosis besides antiphospholipid antibodies in patients with antiphospholipid syndrome].
    Fan YY; Chen C; Liu HJ; Cai WX; Hou YK; Li C
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(43):3588-3593. PubMed ID: 34808753
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic risk assessment in systemic lupus erythematosus: validation of the global antiphospholipid syndrome score in a prospective cohort.
    Sciascia S; Cuadrado MJ; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1915-20. PubMed ID: 24964745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
    Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
    Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.